Sildenafil reverses hypoxic pulmonary hypertension in highland and lowland newborn sheep

Pediatric Research

Volumn 63, Issue 2, 2008, Pages 169-175

  Herrera, Emilio A ^a   Ebensperger, Germán ^a,c   Krause, Bernardo J ^a   Riquelme, Raquel A ^a   Reyes, Roberto V ^a   Capetillo, María ^a   González, Sergio ^b   Parer, Julian T ^d   Llanos, Aníbal J ^a,c,e  

^a UNIVERSITY OF CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSIDAD DE TARAPACÁ   (Chile)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V; SILDENAFIL;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HEART OUTPUT; HYPOXIA; LUNG ARTERY PRESSURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; VASODILATATION;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMICS; HYPERTENSION, PULMONARY; MODELS, BIOLOGICAL; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PULMONARY ARTERY; PURINES; RNA, MESSENGER; SHEEP; SHEEP, DOMESTIC; SULFONES; VASODILATOR AGENTS;

EID: 38349156463     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31815ef71c     Document Type: Article

References (43)

1. Herrera EA, Pulgar VM, Riquelme RA, Sanhueza EM, Reyes RV, Ebensperger G, Parer JT, Valdez EA, Giussani DA, Blanco CE, Hanson MA, Llanos AJ 2007 High-altitude chronic hypoxia during gestation and after birth modifies cardiovascular responses in newborn sheep. Am J Physiol Regul Integr Comp Physiol 292:R2234-R2240
2. Tucker A, McMurtry IF Reeves JT, Alexander AF, Will DH, Grover RF 1975 Lung vascular smooth muscle as a determinant of pulmonary hypertension at altitude. Am J Physiol 228:762-767
3. Monge C, Leon-Velarde F 1991 Physiological adaptation to high altitude: oxygen transport in mammals and birds. Physiol Rev 71:1135-1172
4. Jeffery TK, Morrell NW 2002 Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis 45:173-202
5. Abman SH 1999 Abnormal vasoreactivity in the pathophysiology of persistent pulmonary hypertension of the newborn. Pediatr Rev 20:e103-e109
6. Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, Verter J, Stoll BJ, Lemons JA, Papile LA, Shankaran S, Donovan EF, Oh W, Ehrenkranz RA, Fanaroff AA 2000 Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 105:14-20
7. Keyes LE, Armaza JF, Niermeyer S, Vargas E, Young DA, Moore LG 2003 Intrauterine growth restriction, preeclampsia, and intrauterine mortality at high altitude in Bolivia. Pediatr Res 54:20-25
8. Peñaloza D, Arias-Stella J 2007 The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness. Circulation 115:1132-1146
9. Shimoda LA, Sham JS, Sylvester JT 2000 Altered pulmonary vasoreactivity in the chronically hypoxic lung. Physiol Res 49:549-560
10. Le Cras TD, McMurtry IF 2001 Nitric oxide production in the hypoxic lung. Am J Physiol Lung Cell Mol Physiol 280:L575-L582
11. Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA 2003 Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res 93:280-291
12. Weimann J, Ullrich R, Hromi J, Fujino Y, Clark MW, Bloch KD, Zapol WM 2000 Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. Anesthesiology 92:1702-1712
13. Shekerdemian LS, Ravn HB, Penny DJ 2002 Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 165:1098-1102
14. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, Kourembanas S 2001 Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci U S A 98:8798-8803
15. Maclean MR, Johnston ED, Mcculloch KM, Pooley L, Houslay MD, Sweeney G 1997 Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension. J Pharmacol Exp Ther 283:619-624
16. Hanson KA, Ziegler JW, Rybalkin SD, Miller JW, Abman SH, Clarke WR 1998 Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity. Am J Physiol 275:L931-L941
17. Murray F, MacLean MR, Pyne NJ 2002 Increased expression on the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension. Br J Pharmacol 137:1187-1194
18. Pauvert O, Bonnet S, Rousseau E, Marthan R, Savineau JP 2004 Sildenafil alters calcium signaling and vascular tone in pulmonary arteries from chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 287:L577-L583
19. Mauricio MD, Segarra G, Medina P, Aldasoro M, Martinez-Leon JB, Vila JM 2006 Relaxation and cyclic GMP levels in response to sildenafil in human pulmonary arteries from donors. Eur J Pharmacol 530:259-262
20. Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR 2001 Sildenafil inhibits hypoxiainduced pulmonary hypertension. Circulation 104:424-428
21. Stenmark KR, Fagan KA, Frid MG 2006 Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 99:675-691
22. Maggiorini M 2003 Cardio-pulmonary interactions at high altitude. Pulmonary hypertension as a common denominator. Adv Exp Med Biol 543:177-189
23. Durmowicz AG, Stenmark KR 1999 Mechanisms of structural remodelling in chronic pulmonary hypertension. Pediatr Rev 20:e91-e102
24. Stenmark KR, Davie N, Frid M, Gerasimovskaya E, Das M 2006 Role of the adventitia in pulmonary vascular remodeling. Physiology (Bethesda) 21:134-145
25. Kinsella JP, Abman SH 2000 Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia. J Pediatr 136:717-726
26. Baquero H, Soliz A, Neira F, Venegas ME, Sola A 2006 Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 117:1077-1083
27. Lorch SA, Cnaan A, Barnhart K 2004 Cost-effectiveness of inhaled nitric oxide for the management of persistent pulmonary hypertension of the newborn. Pediatrics 114:417-426
28. Walsh MC, Stork EK 2001 Persistent pulmonary hypertension of the newborn. Clin Perinatol 28:609-627
29. Keogh AM, McNeil KD, Williams T, Gabbay E, Cleland LG 2003 Pulmonary arterial hypertension: a new era in management. Med J Aust 178:564-567
30. Mathai SC, Girgis RE, Fisher MR, Champion HC, Housten-Harris T, Zaiman A, Hassoun PM 2007 Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension. Eur Respir J 29:469-475
31. Shekerdemian LS, Penny DJ, Ryhammer PK, Reader JA, Ravn HB 2004 Endothelin-A receptor blockade and inhaled nitric oxide in a porcine model of meconium aspiration syndrome. Pediatr Res 56:353-358
32. Travadi JN, Patole SK 2003 Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review. Pediatr Pulmonol 36:529-535
33. Ichinose F, Erana-Garcia J, Hromi J, Raveh Y, Jones R, Krim L, Clark MW, Winkler JD, Bloch KD, Zapol WM 2001 Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension. Crit Care Med 29:1000-1005
34. Carroll WD, Dhillon R 2003 Sildenafil as a treatment for pulmonary hypertension. Arch Dis Child 88:827-828
35. Obaid L, Johnson ST, Bigam DL, Cheung PY 2006 Intratracheal administration of sildenafil and surfactant alleviates the pulmonary hypertension in newborn piglets. Resuscitation 69:287-294
36. Binns-Loveman KM, Kaplowitz MR, Fike CD 2005 Sildenafil and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets. Pediatr Pulmonol 40:72-80
37. Juliana AE, Abbad FC 2005 Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil. Eur J Pediatr 164:626-629
38. Shekerdemian LS, Ravn HB, Penny DJ 2004 Interaction between inhaled nitric oxide and intravenous sildenafil in a porcine model of meconium aspiration syndrome. Pediatr Res 55:413-418
39. de Rosalmeida MC, Saraiva LD, da Graca JR, Ivo BB, da Nobrega MV, Gondim FA, Rola FH, dos Santos AA 2003 Sildenafil, a phosphodiesterase-5 inhibitor, delays gastric emptying and gastrointestinal transit of liquid in awake rats. Dig Dis Sci 48:2064-2068
40. Balacco Gabrieli C, Regine F, Vingolo EM, Rispoli E, Isidori A 2003 Acute electroretinographic changes during sildenafil (Viagra) treatment for erectile dysfunction. Doc Ophthalmol 107:111-114
41. Marsh CS, Marden B, Newsom R 2004 Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension. Br J Ophthalmol 88:306-307
42. Milman HA, Arnold SB 2002 Neurologic, psychological, and aggressive disturbances with sildenafil. Ann Pharmacother 36:1129-1134
43. Wang M, Urenjak J, Fedele E, Obrenovitch TP 2004 Effects of phosphodiesterase inhibition on cortical spreading depression and associated changes in extracellular cyclic GMP. Biochem Pharmacol 67:1619-1627